DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound
DeepHealth, a wholly owned subsidiary of RadNet, received FDA 510(k) clearance for its AI-powered Breast Ultrasound solution, automating lesion detection, characterization, and reporting. Clinical validation demonstrated over 98% accuracy in lesion localization and an 8% improvement in sensitivity, while reducing radiologist interpretation time by 37%.
Key figures
- Annual eligible studies
- 700000
- Sensitivity improvement
- 8%
- Lesion localization accuracy
- 98%
- Interpretation time reduction
- 37%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.